Hosted on MSN40m
Sanofi’s Sarclisa combo approved in China for multiple myelomaSanofi has received China’s National Medical Products Administration (NMPA) approval for the use of Sarclisa (isatuximab), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback